Skip to content

HRTX

Heron Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.34
+4.21%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-20.0%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 10, 2026Hensley Mark Earl · officer: Chief Operating OfficerM-Exempt31,250$0.00
Aug 10, 2026Hensley Mark Earl · officer: Chief Operating OfficerF-InKind8,888$0.50
Aug 3, 2026Forbes William P · officer: EVP, Chief Development OfficerM-Exempt11,769$0.00
Aug 3, 2026Collard Craig A · director, officer: Chief Executive OfficerM-Exempt50,021$0.00
Aug 3, 2026Duarte Ira · officer: EVP, Chief Financial OfficerM-Exempt11,694$0.00
Aug 3, 2026Duarte Ira · officer: EVP, Chief Financial OfficerM-Exempt13,535$0.00
Aug 3, 2026Forbes William P · officer: EVP, Chief Development OfficerM-Exempt11,694$0.00
Aug 3, 2026Duarte Ira · officer: EVP, Chief Financial OfficerF-InKind3,326$0.50
Aug 3, 2026Duarte Ira · officer: EVP, Chief Financial OfficerF-InKind3,850$0.50
Aug 3, 2026Forbes William P · officer: EVP, Chief Development OfficerF-InKind3,348$0.50
Aug 3, 2026Forbes William P · officer: EVP, Chief Development OfficerF-InKind3,326$0.50
Aug 3, 2026Collard Craig A · director, officer: Chief Executive OfficerM-Exempt34,789$0.00
Aug 3, 2026Hensley Mark Earl · officer: Chief Operating OfficerM-Exempt11,769$0.00
Jul 20, 2026Forbes William P · officer: EVP, Chief Development OfficerM-Exempt3,874$0.00
Jul 20, 2026Forbes William P · officer: EVP, Chief Development OfficerF-InKind1,101$0.47
Jul 20, 2026Collard Craig A · director, officer: Chief Executive OfficerM-Exempt13,797$0.00
Jul 20, 2026Duarte Ira · officer: EVP, Chief Financial OfficerM-Exempt3,874$0.00
Jul 20, 2026Duarte Ira · officer: EVP, Chief Financial OfficerF-InKind1,101$0.47
Jun 17, 2026Duarte Ira · officer: EVP, Chief Financial OfficerF-InKind3,555$0.38
Jun 17, 2026Duarte Ira · officer: EVP, Chief Financial OfficerM-Exempt12,500$0.00
Jun 8, 2026Forbes William P · officer: EVP, Chief Development OfficerM-Exempt12,500$0.00
May 7, 2026Hensley Mark Earl · officer: Chief Operating OfficerM-Exempt125,000$0.00
May 4, 2026Duarte Ira · officer: EVP, Chief Financial OfficerM-Exempt11,694$0.00
May 4, 2026Collard Craig A · director, officer: Chief Executive OfficerM-Exempt34,789$0.00
May 4, 2026Hensley Mark Earl · officer: Chief Operating OfficerM-Exempt11,770$0.00
May 4, 2026Forbes William P · officer: EVP, Chief Development OfficerM-Exempt11,694$0.00
May 4, 2026Collard Craig A · director, officer: Chief Executive OfficerM-Exempt50,021$0.00
May 4, 2026Forbes William P · officer: EVP, Chief Development OfficerM-Exempt11,770$0.00
May 4, 2026Duarte Ira · officer: EVP, Chief Financial OfficerM-Exempt13,535$0.00
Apr 21, 2026Forbes William P · officer: EVP, Chief Development OfficerM-Exempt3,874$0.00
Institutional positioning

13F filings over the trailing two quarters

New 52Increased 112Reduced 89Sold out 21
FilerActionSharesFiled
RUBRIC CAPITAL MANAGEMENT LPUnchanged30,046,828May 15, 2026
Rubric Capital Management LPUnchanged30,046,828Aug 14, 2026
CLEARLINE CAPITAL LPUnchanged12,235,239May 15, 2026
Clearline Capital LPReduced11,383,961Aug 14, 2026
BlackRock, Inc.Increased10,550,750Aug 7, 2026
BLACKROCK, INC.Reduced10,106,422May 13, 2026
ORBIMED ADVISORS LLCNew Position9,816,940May 15, 2026
VELAN CAPITAL INVESTMENT MANAGEMENT LPUnchanged8,753,290May 15, 2026
Velan Capital Investment Management LPUnchanged8,753,290Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position7,810,329May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCReduced7,782,741Aug 13, 2026
MILLENNIUM MANAGEMENT LLCIncreased7,630,527May 15, 2026
Tejara Capital LtdIncreased6,510,795Aug 11, 2026
TEJARA CAPITAL LTDIncreased6,336,755May 12, 2026
TANG CAPITAL MANAGEMENT LLCUnchanged6,250,000Aug 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 10, 2026